Tuesday, September 23, 2025

Nuclear-Armed Sea-Launched Cruise Missile (SLCMN) – Analysis

The W76 is delivered via the Trident II, D5 submarine-launched ballistic missile. This image shows the D5 being tested. Photo Credit: Los Alamos National Laboratory

By 

By Anya L. Fink


Congress and the executive branch have debated the merits of a new nuclear-armed sea-launched cruise missile (SLCM-N) since the weapon was proposed by the first Trump Administration in 2018.

The Biden Administration proposed cancelling the SLCM-N program following its 2022 Nuclear Posture Review (NPR), a periodic assessment of U.S. nuclear policy. Congress has provided funding for the SLCM-N and its warhead; the FY2024 National Defense Authorization Act (NDAA) required the executive branch to ensure SLCM-N initial operational capability (IOC). Since the FY2024 NDAA, the U.S. Navy has taken steps to implement the SLCM-N program.

Background

The Navy first deployed a nuclear-armed sea-launched cruise missile in the mid-1980s, when it placed the TLAM-N—a nuclear-armed version of the Tomahawk land-attack cruise missile—on surface ships and attack submarines. With a range of 2,500 kilometers (about 1,550 miles), the missiles were not included in the limits of U.S.-Soviet arms control agreements.

In 1991, at the end of the Cold War, President George H.W. Bush announced that the United States would withdraw all land-based tactical nuclear weapons (those that could travel less than 300 miles) from overseas bases and all sea-based tactical nuclear weapons from surface ships, submarines, and naval aircraft. The Navy withdrew the TLAM-N missiles by mid-1992 and eliminated the nuclear mission for U.S. surface ships, but retained the option to return the TLAM-N to attack submarines. Some observers characterized this redeployment ability as demonstrating the credibility of U.S. defense commitments to allies in Asia. 

In 2010, the Obama Administration recommended that the Navy retire the TLAM-N missiles. The 2010 NPR stated that “this system serves a redundant purpose,” as it was one of several weapons the United States could deploy in support of U.S. allies. The Navy completed the retirement of these missiles in 2013.


The first Trump Administration reversed this decision, arguing in the 2018 NPR that a nuclear-armed sea-launched cruise missile (now known as SLCM-N) would provide the United States with a “non-strategic regional presence” that would address the “need for flexible and low-yield options.” SLCM-N was one of two systems that the 2018 NPR characterized as “modest supplements” that would “strengthen deterrence” of regional adversaries and assure U.S. allies.

The other 2018 NPR-recommended system was a low-yield version of the W76 nuclear warhead (known as the W76-2) for the Trident D5 long-range submarine-launched ballistic missile (SLBM). The 2018 NPR stated that the W76-2 was an option for the “near-term,” while SLCM-N would be an option implemented over “the longer term.” The Department of Defense (DOD) announced the deployment of the W76-2 in 2020. The Navy conducted an Analysis of Alternatives on the SLCM-N.

In its FY2022 budget request, the Biden Administration sought $5.2 million for DOD research and development work on the SLCM-N. It also requested $10 million for the National Nuclear Security Administration (NNSA) to study adapting the W80-4 nuclear warhead, intended for the Long-Range Standoff Weapon (LRSO) air-launched cruise missile, for delivery carried by the SLCM-N. Later, in the 2022 NPR, the Biden Administration proposed cancelling the SLCM-N, arguing that the missile was “no longer necessary” because of the W76-2 SLBM’s “deterrence contribution.” The Navy’s FY2023 budget request eliminated funding for the SLCM-N, stating that it was “cost prohibitive and the acquisition schedule would have delivered capability late to need.” 

Current Status

The Biden Administration did not include the SLCM-N in its FY2023, FY2024, or FY2025 budget requests. The Administration’s policy statements on the FY2023 and FY2024 NDAAs asserted that continuing the SLCM-N program “would divert resources and focus from higher modernization priorities.” Despite the Administration’s objections, Congress has provided continued funding for the missile and the associated warhead (see Table 1). 

Table 1. Funding for SLCM-N ($ in millions)

Authorizations and Appropriations FY2023 FY2024 FY2025
Authorized for SLCM-N25.0190.0252.0
Appropriated for SLCM-N25.0130.0n/a
Authorized for SLCM-N warhead20.070.070.0
Appropriated for SLCM-N warhead20.070.0n/a 
Source: P.L. 117-263P.L. 118-31P.L. 117-328P.L. 118-47P.L. 118-42P.L. 118-159.

Section 1640 of the FY2024 NDAA (P.L. 118-31) directed DOD to establish a “major defense acquisition program” for SLCM-N under the Under Secretary of Defense for Acquisition and Sustainment (USD A&S), initiate a program to alter the W80-4 warhead for delivery via SLCM-N, and “ensure” that the system achieves IOC no later than September 30, 2034. 

Then-USD A&S William LaPlante testified in April 2024 that in March 2024 he directed the “Navy to establish a [SLCM-N] program office and to begin the analysis phase.” He also stated that the Nuclear Weapons Council, a joint DOD-NNSA coordination group, was “leading a review of options to execute the SLCM-N program in a manner that balances cost, deterrence value, and risk to the [nuclear modernization] program of record and the Joint Force.” 

Section 1627 of the FY2025 NDAA (P.L. 118-159) provided DOD and NNSA with flexibility to select an alternative warhead for the SLCM-N; directed the Secretary of the Navy to establish a “separate, dedicated program element” for SLCM-N development in the FY2026 budget request; and limited certain funding unless the Secretary of the Navy certifies the establishment of a program office. 

Vice Admiral Johnny Wolfe, Director of the Navy’s Strategic Systems Programs (SSP), testified in a May 2025 hearing that SSP was working to understand the challenges of developing and integrating the SLCM-N onto the Virginia-Class submarine. A May 2025 NNSA document stated that NNSA plans to use the “W80 warhead family” for the SLCM-N warhead. In August 2025, SSP and Naval Surface Warfare Center (NSWC), Crane Division, issued awards for the development of SLCM-N prototype designs.

The second Trump Administration did not request discretionary funding for SLCM-N (program element 0105519N) in the FY2026 Navy budget, assuming $1.92 billion in mandatory funding from FY2025 reconciliation legislation (P.L. 119-21), commonly referred to as the One Big Beautiful Bill Act. The FY2026 NNSA request assumed $272 million for the warhead. The FY2025 reconciliation legislation included $2 billion for DOD to accelerate work on the missile and $400 million for NNSA to accelerate work on the warhead.

The Senate Armed Services Committee-reported FY2026 NDAA (§1517 of S. 2296) proposes to authorize the DOD to use middle-tier rapid prototyping authority, to advance the IOC from 2034 to 2032, and to fund the missile at $320 million and the warhead at $186 million. The House Armed Services Committee-reported FY2026 NDAA (H.R. 3838) proposes to fund the missile and the warhead at $100 million each. 

Issues in the SLCM-N Debate

Deterrence Credibility and Flexibility of Options

A key issue in the SLCM-N debate is whether adding the missile to U.S. nuclear forces is necessary to credibly deter limited nuclear use by adversaries and assure allies in Europe and the Asia-Pacific that the United States would protect them from nuclear coercion. The Biden Administration stated in 2023 that the United States has the ability in its “current and planned capabilities for deterring an adversary’s limited nuclear use through conventional and nuclear armaments,” including the W76-2 SLBM and air-delivered weapons such as the “Air-launched Cruise Missile, its successor… [the LRSO], and F-35A dual-capable aircraft that can be equipped with B61-12 nuclear gravity bombs.” (See CRS In Focus IF12735, U.S. Extended Deterrence and Regional Nuclear Capabilities.)

SLCM-N proponents have argued that SLCM-N’s attributes are different from low-yield capabilities delivered by other means. They say that aircraft that deliver weapons would need to either be “generated” (fueled, weapons-loaded, and flown) from the United States, which takes time, or else placed in regional bases, where they could be vulnerable to adversary strikes. SLCM-N proponents also argue that deploying the missile on surface vessels or attack submarines provides advantages, such as greater availability and regional presence, over deploying the W76-2 SLBM on ballistic missile submarines.

STRATCOM Commander General Anthony Cotton reportedly wrote in 2023 that “a low-yield, non-ballistic nuclear capability to deter, assure and respond without visible generation” could provide the President with additional signaling and response options in a crisis. In April 2022 testimony, General Mark Milley, then-Chairman of the Joint Chiefs of Staff, also expressed support for the SLCM-N. The 2023 final consensus report of the Congressional Commission on the Strategic Posture of the United States did not explicitly endorse the SLCM-N, but called for a prompt system that is “forward deployed or deployable”; “survivable against preemptive attack without force generation day-to-day”; possesses “a range of explosive yield options, including low yield”; and is able to penetrate adversary integrated air and missile defenses. 

Observers have debated whether a U.S. nuclear posture that includes low-yield capabilities like the SLCM-N and the W76-2 and demonstrates a willingness to use nuclear weapons improves deterrence and allied assurance or increases the risk of nuclear war. 

Arms Control 

Policymakers have debated the potential role of SLCM-N in arms control. The 2018 NPR linked the missile to U.S. concerns about a new missile that Russia has deployed in violation of the 1987 Intermediate-Range Nuclear Forces (INF) Treaty. Although the United States withdrew from the treaty in 2018, the 2018 NPR stated that SLCM-N could provide a treaty-compliant U.S. response to Russia’s violation and incentivize Russia to engage in arms control on nonstrategic nuclear weapons. In contrast, the 2022 NPR argued that there is “uncertainty regarding whether SLCM-N on its own would provide leverage” in such negotiations. Russia has rejected negotiations concerning its nonstrategic nuclear weapons, citing these capabilities as necessary to offset to U.S. and NATO conventional superiority. 

Operational Tradeoffs and Costs 

The Biden Administration argued in a July 2023 policy statement that “deploying SLCM-N on Navy attack submarines or surface combatants would reduce capacity for conventional strike munitions, create additional burdens on naval training, maintenance, and operations, and could create additional risks to the Navy’s ability to operate in key regions.” In May 2024 testimony, then-Navy Secretary Carlos Del Toro expressed concerns about the tactical and operational tradeoffs and costs of SLCM-N for the Navy. 

The 2022 NPR also cited the SLCM-N’s “estimated cost” as a tradeoff. The Navy stated in 2022 that SLCM-N cancellation would save $199.2 million in FY2023 and $2.1 billion over the next five years. Secretary of Defense Lloyd Austin III testified in April 2022 that “the marginal capability that [the SLCM-N] provides is far outweighed by the cost.” A July 2023 Congressional Budget Office (CBO) report estimated the costs of SLCM-N and its warhead at $10 billion from 2023-2032 “if the program began in 2024.” This amount, the CBO noted, does not include production costs beyond 2032, or costs for systems integration, storage, or operations. SLCM-N supporters argue that the deterrence and assurance benefits of SLCM-N outweigh these operational tradeoffs and costs.

  • About the author: Anya L. Fink, Analyst in U.S. Defense Policy

CRS

The Congressional Research Service (CRS) works exclusively for the United States Congress, providing policy and legal analysis to committees and Members of both the House and Senate, regardless of party affiliation. As a legislative branch agency within the Library of Congress, CRS has been a valued and respected resource on Capitol Hill for nearly a century.

TELEPORTATION

U-M quantum testbed enables remote experiments




The optical fibers connecting two quantum research labs at the University of Michigan mark the first piece of a local quantum network and remote user test facility



University of Michigan


 




Photos of Parag and Zheshen in their respective labs  //  Video

 

 

Researchers and students can now remotely run new kinds of quantum experiments on campus at the University of Michigan, thanks to the establishment of a quantum testbed that links two labs with optical fibers. 

 

The ultimate aim is to provide broader access to the tools needed for quantum technology development and build a robust educational resource based on the experimental data. 

 

Quantum researchers, who explore the behavior of particles and light at scales smaller than a single atom, often have to deal in theory because they lack the facilities and resources to fully test their predictions. For instance, entanglement—a phenomenon in which two particles become linked so that measuring one instantly changes the state of the other—may be tested over distances of miles at just a handful of facilities with restricted, in-person access. 

 

Lacking travel resources, many quantum researchers work within a single lab. This makes it hard to take advantage of entangled light that may be transferred and measured over long distances.

 

Now, an optical fiber link has been installed between the labs of Zheshen Zhang and Parag Deotare, two associate professors of electrical and computer engineering. The link allows them to use light to transfer encrypted or entangled information between their facilities in the Electrical Engineering and Computer Science Building on North Campus and the Randall Laboratory on Central Campus, about three miles apart.

 

The transfer of information encoded in light through glass fibers isn't new—you may even be using fiber internet to read this story. But the transfer of quantum information (qubits) over these fibers could revolutionize communication, computing, scientific discovery and more with its speed and privacy protection.

 

"You can think about this link as an extension of the current internet, with telecommunication fibers transmitting optical signals, but now we have the new capability to distribute quantum states of light in addition to classical states of light," Zhang said.

 

The research team has already run some basic experiments on the testbed and demonstrated that they can transport entangled light across the link. The team has also developed a set of interactive demonstrations that allow researchers and students to learn quantum theory and then see how the theory plays out in real life with data prerecorded on the testbed during actual experiments. Anyone can try them at qreal.cloud.

 

Because specialized hardware is required to generate quantum states of light or perform other quantum experiments, access to quantum science and technology development has been restricted to people in very high-resource settings. This has created a barrier for the broader community—at universities or industry partners that lack these facilities—to apply their talents to advancing quantum technology. 

 

Zhang and Deotare aim to dismantle that obstacle for researchers.

 

"If we can create a portal that allows external users to remotely access the testbed resources, that greatly facilitates technology advancement and technology transfer," Zhang said.

 

The collaboration between Zhang and Deotare is just the beginning. They aim to connect additional quantum research facilities at the University of Michigan, at other local universities and in local industry, creating a larger-scale quantum network for all types of quantum experimentation.

 

"Part of this project is also education and workforce development," said Deotare, who is also an associate professor of physics. "The distributed network that we're creating would serve as excellent infrastructure for industry folks to visit and spend a couple of weeks trying to understand quantum experiments at a distributed network level and getting experience with an actual system."

 

A local fiber infrastructure already exists in many places across Ann Arbor, facilitating the connections by Zhang and Deotare. They are collaborating with Merit Network, a local service provider that oversees telecommunication fiber links to local community colleges and industries, to expand their testbed network infrastructure.

 

Between the two labs, the network already has access to equipment that can create entanglement and detect it. They plan to incorporate additional labs that use a variety of physical quantum platforms, including neutral atoms, 2D materials, trapped ions and superconducting qubits—many of which already exist at Michigan.

 

"Our testbed would serve as the backbone of interconnecting quantum systems, and, in turn, advance the development of different quantum systems," Zhang said. "Our vision is that the testbed becomes a local engine for innovation and workforce development."

 

Ph.D. students Alexander McFarland, Visuttha Manthamkarn and Kailu Zhou, all in electrical and computer engineering, were instrumental in setting up the connection and remote testing capability. The research and development of the testbed has been funded by the U-M Office of the Vice President for Research. The educational aspects of the project have been supported by the National Science Foundation.

 

Penn State Health’s patient-centered quality metric reframing project may serve as a model for presenting future quality metrics



Patient-oriented quality metrics enhance provider and staff engagement



American Academy of Family Physicians




Innovations in Primary Care

 

Penn State Health’s Patient-Centered Quality Metric Reframing Project May Serve as a Model for Presenting Future Quality Metrics 

Quality metrics aim to improve patient outcomes by setting evidence-based targets, but many are neither patient centered nor physician centered. A team at Penn State Health’s Department of Family and Community Medicine ran a project across 13 ambulatory clinics to make quality data more meaningful by presenting patient-oriented outcomes in plain, natural language. Using 24 months of electronic health record data, they paired measured outcomes with Number Needed to Treat (NNT)–based estimates to translate care delivered into likely patient results, such as, “you avoided four strokes for patients with heart disease by prescribing statins, for example.” They produced one-page summaries, emailed clinic-level and provider-level reports, and displayed office posters, then surveyed recipients. Among 119 respondents, most said the reports were clear (85%) and relevant (77%); many felt the format strengthened their sense of impact compared with standard metrics (61%), increased motivation (59%), and would improve how they review traditional measures (50%). About half wanted clearer explanations of how the numbers were calculated, pointing to a need for more transparency.  

Permanent link: Patient-Oriented Quality Metrics Enhance Provider and Staff Engagement

Daniel Schlegel, MD, MHA, DABFM, FAAFP, et al

Penn State Health & Penn State College of Medicine, Hershey, Pennsylvania

CHART guideline provides 12 key reporting items for AI chatbot health advice studies


Reporting guideline for chatbot health advice studies: Chatbot Assessment Reporting Tool (CHART) statement




American Academy of Family Physicians





Special Report

CHART Guideline Provides 12 Key Reporting Items for AI Chatbot Health Advice Studies

Background and Goal: In response to the growing need for reporting standards for evaluating artificial intelligence (AI) chatbot health advice studies for clinical purposes, researchers created the Chatbot Assessment Reporting Tool (CHART) so stakeholders can interpret results with confidence.

Key Insights: CHART was developed through a systematic review; a Delphi consensus process (a series of anonymous expert surveys to build agreement) with 531 international stakeholders; and three consensus meetings with a 48-member expert panel. The CHART statement outlines 12 key reporting items for chatbot health advice studies in the form of a checklist and methodological diagram.

Why It Matters: The CHART checklist and corresponding diagram of the method can support key stakeholders, including health system administrators, clinicians, researchers, editors, peer reviewers, and readers in reporting, understanding, and interpreting the findings of chatbot health advice studies. 

Permanent link: Reporting Guideline for Chatbot Health Advice Studies: Chatbot Assessment Reporting Tool (CHART) Statement

Bright Huo, et al

Dalhousie University, Halifax, Canada

 

The Lancet: Experts outline healthcare, policy, and social changes needed to make the most of Alzheimer’s treatment breakthroughs



The Lancet





The approval of new antibody medications for Alzheimer's disease – lecanemab and donanemab – and diagnostic tests in the blood mark the beginning of a new era in Alzheimer's disease diagnosis and treatment. However, without rapid reform in healthcare systems, public policy, and societal attitudes, their potential will not be fully realised, argue 40 leading Alzheimer's disease experts in The Lancet Series on Alzheimer's disease.

Alzheimer's disease accounts for about 70% of all dementia cases and is a leading cause of disability, resulting in high societal and economic costs.

In a novel comparison, the Series highlights that the new monoclonal antibody treatments can slow Alzheimer's disease progression to a level comparable to the efficacy of medicines for cancer, rheumatoid arthritis and multiple sclerosis. However, the authors say that differences in age, patient outcomes, and side effects mean such comparisons should be treated cautiously.

Disease 

Alzheimer’s (Lecanemab) 

Alzheimer’s (Donanemab) 

Early stage breast cancer 

Lung cancer 

Multiple sclerosis 

Rheumatoid arthritis 

Efficacy in delaying progression 

8% 

10% 

9% 

32% 

4% 

n/a 

Reduction in progression on disability scales  

0.19 

0.26 

n/a 

 

n/a 

 

0.20 

0.25 

For a more detailed comparison see table 2, page 8 in the third paper ‘Alzheimer's disease outlook: controversies and future directions’ 

Despite the similarity in treatment effectiveness for other diseases, high costs of medication, complex testing requirements, suboptimal care for behavioural symptoms, and under-resourcing risk leaving Alzheimer’s patients behind. 

Encouragingly, improvements in the prevention of Alzheimer's disease are also on the horizon, with emerging Brain Health Services identifying people at a high risk for developing the disease and providing them with personalised treatment programs. Yet most cases of Alzheimer's disease occur in people with low or normal risk, making population-wide measures, which decrease risk – such as healthier urban design and restrictions on alcohol and sugary drinks – essential. 

The authors call for coordinated global action so that the rapid pace of science advancement in the field of Alzheimer's disease is matched by reforms at the level of healthcare providers, policy, and society.  

Lead author of the Series, Professor Giovanni Frisoni, University of Geneva (Switzerland), says: “Blood tests, biological drugs for Alzheimer's disease, and prevention interventions are propelling care into entirely new and exciting territory. However, the old needs of patients will not disappear. On the contrary, more general practitioners and dementia specialists will need to master the less glamorous but steady advances made in the past few decades in the care and treatment of behavioural disorders, the use of sophisticated diagnostic imaging and laboratory tools, and psychosocial care. A concerted societal effort in this direction will enable our current and future patients to benefit fully from the potential of scientific and technological advances.” 

 

A silver lining in sewer sludge: Volatile fatty acids





Washington University in St. Louis





By Leah Shaffer

Many sewage treatment plants are equipped to process waste using anaerobic digestion, in which the sewage sludge is held in an oxygen-free chamber to ferment and break down. As part of that degradation, biogas such as methane can be reclaimed from that sludge. But the process can be expensive because it requires electric generators to convert the biogas to a more useful form such as electricity, and such conversion may not be economically viable when biogas production is at a small scale.

Jason He, the Laura and William Jens Professor of Energy, Environmental and Chemical Engineering at Washington University in St. Louis, wanted to find more efficient ways to get riches out of the rubbish.

 “Can we recover something potentially of higher value than biogas?” he asked.

He and his team looked at short-chain volatile fatty acids (VFA), a common intermediate compound for many materials, including bioplastics.

VFAs can also serve as the feedstock to clean the sewage at lower cost. Treatment facilities could use VFAs from their own sewage to serve as a carbon source for the nitrogen converters and for biological phosphorus removers, He said.

Along with reducing the expense of sewage cleanup, VFAs can be reclaimed in liquid form and potentially sold for use in manufacturing and agricultural processes to further recoup sewage treatment costs.

In work published in Water Research, the McKelcey School of Engineering team shows how using hydrogen peroxide on the sewage will inhibit methanogenesis and send sewage down the path of VFA production instead.

Hydrogen peroxide is a low-cost addition that leads to more than 30 times the VFA production in sludge compared to controls. Even further efficiencies emerged when Jiasi Sun, He’s PhD student and the paper’s first author, noticed how light exposure further improved the efficiency of the process.

Sun saw that two identical reactors were producing different results. She thought at first it was a measurement error, but then realized the one reactor was closer to a light source.

“I realized that light was accelerating the breakdown of hydrogen peroxide into reactive species. That small observation completely changed how I understood the process of reclaiming VFAs,” she said.

The bit of scientific serendipity is sending the team down a new research rabbit hole: bringing light back to the dark fermentation tanks.

“With light, the hydrogen peroxide dosage can be greatly reduced,” He added.

For now, they are exploring the addition of LED lights to the reactors and tinkering with reactor design to push the efficiencies even farther.

“It’s all coming from these unexpected results,” He said.


Sun J, He Z. Light stimulated H2O2 inhibition on methanogenesis during anaerobic digestion towards enhanced VFAs production. Water Research, Volume 286. https://doi.org/10.1016/j.watres.2025.124229

This work was financially supported by the U.S. National Science Foundation (award # 2150613).

Originally published on the McKelvey Engineering website